Combined ileal biomarkers can discriminate responders from non-responders to vedolizumab therapy in Crohn's disease

Mark Osterman  1     Elisabeth M. Davis  2     Ilyssa O. Gordon  3     Kate Simpson  4     Matthew A. Ciorba  5     Sarach C. Glover  6     Bincy P. Abraham     Eric Yee,     Felicia Allard     Brian Claggett     Bo Shen     Thaddeus S. Stappenbeck     Julia Liu    
1 University of Pennsylvania,Philadelphia,United States
2 University of Arkansas for Medical Sciences,Little Rock,United States
3 Cleveland Clinic Foundation, Cleavland,Clevland,United States
4 Washington University School Of Medicine, St Louis, Mo,St. Louis,United States
5 Washington University School of Medicine,St. Louis,United States
6 U

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing